Strefa firm

NUTOPI is an upcoming startup in in vitro diagnostics and offers contract research/development and manufacturing services. Our solutions help small SMEs to get their products from idea to market in small scale to limit time and cost. Our expertise lies within the techniques as ELISA, LFI and Immunoturbidimetry but not limited to, and services as planning, validation and creating reports thereof are also offered.

NUTOPIs most significant achievements have been to develop and manage three products for a Nasdaq North registered company, and to have developed and validated a turbidimetric assay. A recent achievement has been to develop and optimize an ELISA product with the successful manufacture and validation in NUTOPIs facilities. All products have been CE/IVD registered.